Key result
Chronic thrombocytopenia linked to a ~5% higher probability of high resource utilization after CTO PCI.
Why the study?
Data on the impact of chronic thrombocytopenia on outcomes following chronic total occlusion PCI were limited, with most existing studies being case reports focused on postprocedural thrombocytopenia.
Does chronic thrombocytopenia increase health resource utilization and worsen in-hospital outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusion?
Observational (n=216,905)
Yes
Does chronic thrombocytopenia increase health resource utilization and worsen in-hospital outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusion?
Chronic thrombocytopenia is a significant predictor of increased healthcare resource utilization, higher costs, and worse in-hospital outcomes among patients undergoing percutaneous coronary intervention for chronic total occlusion.
Answers are grounded in this paper and cite their sources.
Should not yet change CTO PCI management; leaves open thrombocytopenia's independent role in high resource use.
BACKGROUND: Data on the impact of chronic thrombocytopenia (CT) on outcomes following chronic total occlusion (CTO) percutaneous coronary interventions (PCI) is limited. Most studies are case reports and focused on postprocedural thrombocytopenia. The purpose of this present study is to assess the impact of CT (> one year) on health resource utilization (HRU), in-hospital outcomes, and cost following CTO PCI. METHODS: We used discharge data from the 2016-2018 National Inpatient Sample and propensity score-weighted approach to examine the association between CT and HRU among patients undergoing CTO PCI. HRU was measured as a binary indicator defined as a length of stay greater than seven days and/or discharge to a non-home setting. The cost was measured as total charges standardized to 2018 dollars. Both outcomes were assessed using generalized linear models adjusted for survey year, and baseline characteristics. RESULTS: Relative to its absence, the presence of CT following CTO PCI was associated with a 4.8% increased probability of high HRU (Population Average Treatment Effect (PATE) estimate = 0.048; 95% Confidence Interval (CI) = 0.041-0.055; P<0.001) and approximately $18,000 more in total hospital charges (PATE estimate = +$18,297.98; 95% CI = $15,101.33-$21,494.63, P<0.001). CONCLUSION: Among chronic total occlusion patients undergoing percutaneous coronary intervention, those with chronic thrombocytopenia had higher resource use, including total hospital charges, and worse in-hospital outcomes when compared with those without chronic thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Sheriff Dodoo (2024) conducted an observational in Chronic total occlusion undergoing percutaneous coronary intervention (n=216,905). Chronic thrombocytopenia vs. Absence of chronic thrombocytopenia was evaluated on High healthcare resource utilization (length of stay >7 days or discharge to non-home setting) (PATE 0.048, 95% CI 0.041-0.055, p=<0.001). Among patients undergoing percutaneous coronary intervention for chronic total occlusion, chronic thrombocytopenia was associated with a 4.8% increased probability of high healthcare resource utilization.
Synapse has enriched 10 related papers. Consider them for comparative context: